177 related articles for article (PubMed ID: 16043703)
1. Investigating diversity in human plasma proteins.
Nedelkov D; Kiernan UA; Niederkofler EE; Tubbs KA; Nelson RW
Proc Natl Acad Sci U S A; 2005 Aug; 102(31):10852-7. PubMed ID: 16043703
[TBL] [Abstract][Full Text] [Related]
2. Investigation of human protein variants and their frequency in the general population.
Nedelkov D; Phillips DA; Tubbs KA; Nelson RW
Mol Cell Proteomics; 2007 Jul; 6(7):1183-7. PubMed ID: 17468123
[TBL] [Abstract][Full Text] [Related]
3. Population proteomics: investigation of protein diversity in human populations.
Nedelkov D
Proteomics; 2008 Feb; 8(4):779-86. PubMed ID: 18210367
[TBL] [Abstract][Full Text] [Related]
4. Population proteomics: addressing protein diversity in humans.
Nedelkov D
Expert Rev Proteomics; 2005 Jun; 2(3):315-24. PubMed ID: 16000079
[TBL] [Abstract][Full Text] [Related]
5. High-throughput affinity mass spectrometry.
Kiernan UA; Nedelkov D; Niederkofler EE; Tubbs KA; Nelson RW
Methods Mol Biol; 2006; 328():141-50. PubMed ID: 16785646
[TBL] [Abstract][Full Text] [Related]
6. What can proteomics tell us about platelets?
Burkhart JM; Gambaryan S; Watson SP; Jurk K; Walter U; Sickmann A; Heemskerk JW; Zahedi RP
Circ Res; 2014 Mar; 114(7):1204-19. PubMed ID: 24677239
[TBL] [Abstract][Full Text] [Related]
7. Pre-analytical factors in clinical proteomics investigations: impact of ex vivo protein modifications for multiple sclerosis biomarker discovery.
Pieragostino D; Petrucci F; Del Boccio P; Mantini D; Lugaresi A; Tiberio S; Onofrj M; Gambi D; Sacchetta P; Di Ilio C; Federici G; Urbani A
J Proteomics; 2010 Jan; 73(3):579-92. PubMed ID: 19666151
[TBL] [Abstract][Full Text] [Related]
8. A functional annotation of subproteomes in human plasma.
Ping P; Vondriska TM; Creighton CJ; Gandhi TK; Yang Z; Menon R; Kwon MS; Cho SY; Drwal G; Kellmann M; Peri S; Suresh S; Gronborg M; Molina H; Chaerkady R; Rekha B; Shet AS; Gerszten RE; Wu H; Raftery M; Wasinger V; Schulz-Knappe P; Hanash SM; Paik YK; Hancock WS; States DJ; Omenn GS; Pandey A
Proteomics; 2005 Aug; 5(13):3506-19. PubMed ID: 16104058
[TBL] [Abstract][Full Text] [Related]
9. Characterization of proteins in human pancreatic cancer serum using differential gel electrophoresis and tandem mass spectrometry.
Yu KH; Rustgi AK; Blair IA
J Proteome Res; 2005; 4(5):1742-51. PubMed ID: 16212428
[TBL] [Abstract][Full Text] [Related]
10. Mass spectrometric characterisation of post-translational modification and genetic variation in human tetranectin.
Jaquinod M; Holtet TL; Etzerodt M; Clemmensen I; Thøgersen HC; Roepstorff P
Biol Chem; 1999 Nov; 380(11):1307-14. PubMed ID: 10614823
[TBL] [Abstract][Full Text] [Related]
11. [Functional proteome analysis of human platelets].
Lewandrowski U; Zahedi RP; Moebius J; Sickmann A
Hamostaseologie; 2007 Sep; 27(4):241-5. PubMed ID: 17938761
[TBL] [Abstract][Full Text] [Related]
12. Plasma Proteome Database as a resource for proteomics research.
Muthusamy B; Hanumanthu G; Suresh S; Rekha B; Srinivas D; Karthick L; Vrushabendra BM; Sharma S; Mishra G; Chatterjee P; Mangala KS; Shivashankar HN; Chandrika KN; Deshpande N; Suresh M; Kannabiran N; Niranjan V; Nalli A; Prasad TS; Arun KS; Reddy R; Chandran S; Jadhav T; Julie D; Mahesh M; John SL; Palvankar K; Sudhir D; Bala P; Rashmi NS; Vishnupriya G; Dhar K; Reshma S; Chaerkady R; Gandhi TK; Harsha HC; Mohan SS; Deshpande KS; Sarker M; Pandey A
Proteomics; 2005 Aug; 5(13):3531-6. PubMed ID: 16041672
[TBL] [Abstract][Full Text] [Related]
13. Modification-specific proteomics: characterization of post-translational modifications by mass spectrometry.
Jensen ON
Curr Opin Chem Biol; 2004 Feb; 8(1):33-41. PubMed ID: 15036154
[TBL] [Abstract][Full Text] [Related]
14. Bioinformatics challenges in the proteomic analysis of human plasma.
Foster JM; Martens L
Methods Mol Biol; 2011; 728():333-47. PubMed ID: 21468959
[TBL] [Abstract][Full Text] [Related]
15. Remarkable temporal stability of high-abundance human plasma proteins assessed by targeted mass spectrometry.
Randall SA; McKay MJ; Pascovici D; Mahon K; Horvath L; Clarke SJ; Molloy MP
Proteomics Clin Appl; 2012 Dec; 6(11-12):626-34. PubMed ID: 23002053
[TBL] [Abstract][Full Text] [Related]
16. Multiplexed MRM-based quantitation of candidate cancer biomarker proteins in undepleted and non-enriched human plasma.
Percy AJ; Chambers AG; Yang J; Borchers CH
Proteomics; 2013 Jul; 13(14):2202-15. PubMed ID: 23592487
[TBL] [Abstract][Full Text] [Related]
17. Mass spectrometry-based targeted quantitative proteomics: achieving sensitive and reproducible detection of proteins.
Boja ES; Rodriguez H
Proteomics; 2012 Apr; 12(8):1093-110. PubMed ID: 22577011
[TBL] [Abstract][Full Text] [Related]
18. Facets of individual-specific health signatures determined from longitudinal plasma proteome profiling.
Dodig-Crnković T; Hong MG; Thomas CE; Häussler RS; Bendes A; Dale M; Edfors F; Forsström B; Magnusson PKE; Schuppe-Koistinen I; Odeberg J; Fagerberg L; Gummesson A; Bergström G; Uhlén M; Schwenk JM
EBioMedicine; 2020 Jul; 57():102854. PubMed ID: 32629387
[TBL] [Abstract][Full Text] [Related]
19. A proteomic approach to identify plasma proteins in patients with abdominal aortic aneurysm.
Gamberi T; Puglia M; Guidi F; Magherini F; Bini L; Marzocchini R; Modesti A; Modesti PA
Mol Biosyst; 2011 Oct; 7(10):2855-62. PubMed ID: 21805001
[TBL] [Abstract][Full Text] [Related]
20. Volumetric mass spectrometry protein arrays.
Nedelkov D; Kiernan UA; Niederkofler EE; Tubbs KA; Nelson RW
Methods Mol Biol; 2007; 382():333-43. PubMed ID: 18220241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
